Palmitoylethanolamide
Sponsors
University of Modena and Reggio Emilia, Arizona State University, Immunoflex Therapeutics Inc., University of California, Irvine, University of Maryland, Baltimore
Conditions
Bipolar DepressionCOVID19Chronic Post-operative PainDyspepsia and Other Specified Disorders of Function of StomachFibula FractureImmunity DisordersInflammationKnee Fracture
Early Phase 1
Phase 2
Unknown Phase
Palmitoylethanolamide for Post-operative Pain Prevention
NCT01491191
Start: 2012-01-31End: 2013-07-31Target: 300Updated: 2011-12-13
Effect of Palmitoylethanolamide on Proinflammatory Markers in Adults Recently Diagnosed With COVID-19
CompletedNCT04912921
Start: 2020-10-20End: 2022-05-15Updated: 2023-03-08
Immune Diversity Response to Oral Dosing of Nutritional Health Products in Healthy Participants
CompletedNCT05242718
Start: 2021-01-10End: 2021-05-20Updated: 2022-02-16
Mechanisms of Palmitoylethanolamide (PEA) to Alter Pain Sensitivity in Knee Osteoarthritis
CompletedNCT05406726
Start: 2023-03-22End: 2024-01-02Updated: 2024-11-05
PEA in Functional Dyspepsia
RecruitingNCT05877781
Start: 2021-11-29End: 2025-03-01Target: 100Updated: 2024-07-01